NICardipine for Fast Achievement of Systolic BP Targets in ICH
Recruiting
Phase 4
Interventional Study
Intracerebral Haemorrhage
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Prior Safety Data
This treatment has already been tested in at least one earlier human trial.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Trial phase
- Phase 4
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 88 (estimated)
- Sponsor
- Aarhus University Hospital · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Quality improvement study with a quasi-randomized design. The study monitors the effect of a gradually implemented treatment algorithm prioritizing intravenous antihypertensives (e.g., nicardipine) over long-acting nitrate patches. It aims to increase the proportion of patients reaching target systolic BP \<140 mmHg within 1 hour of hospital admission while monitoring safety, clinical outcomes, an…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Age ≥18 years
* Acute spontaneous Intracerberal Hemorrhage confirmed by imaging
* Symptom onset to stroke center admission \<6 hours
* Elevated systolic blood pressure (\>140 mmHg) at admission
Exclusion Criteria:
* Secondary causes of ICH (e.g., trauma, vascular malformatio…
Contacts